Related Experiment Video
Updated: May 7, 2026
09:07
Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations
Published on: September 16, 2015
[Contracts including performance and management of uncertainty]
G Duru1, P Garassus, J-P Auray
1CYKLAD, 16, rue André-Le-Nôtre, 69140 Rillieux, France.
Annales Pharmaceutiques Francaises
|October 1, 2013
Summary
France aims to control high drug spending by linking pharmaceutical prices to treatment outcomes. This strategy involves conditional pricing and long-term monitoring for new drugs, balancing industry needs with public health insurance coverage.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Pharmacoeconomics
Context:
- France faces significant ambulatory healthcare expenditure driven by high drug consumption, making it the world's largest consumer of pharmaceuticals.
- Regulatory authorities implement strategies to limit market access for new drugs under public social insurance coverage.
- Traditional methods focus on reimbursement based on scientific studies and price negotiation.
Purpose:
- To explore the challenges and implications of a new market access strategy for pharmaceuticals in France.
- To analyze the concept of conditional drug pricing linked to performance and patient outcomes.
- To examine the regulatory framework and follow-up mechanisms for 'outcome' contracts between French authorities and pharmaceutical industries.
Summary:
- New trends in pharmaceutical pricing involve dual approaches, integrating performance and outcome-based contracts.
- These contracts introduce uncertainty by linking initial market access and pricing to the long-term success and efficacy of new treatments.
- The framework includes reciprocal partnerships with defined rules for non-compliance, addressing uncertainties in treatment development and diffusion.
Impact:
- This approach introduces a novel dimension of uncertainty into market access strategies, necessitating adapted follow-up mechanisms.
- Conditional drug pricing and outcome-based contracts represent a significant shift in the economic context of pharmaceutical regulation in France.
- The study provides insights into the evolving relationship between regulatory bodies and the pharmaceutical industry in managing drug costs and ensuring therapeutic value.
Related Concept Videos
00:59Uncertainty: Overview
In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
00:54Uncertainty: Confidence Intervals
The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...
00:59Propagation of Uncertainty from Random Error
An experiment often consists of more than a single step. In this case, measurements at each step give rise to uncertainty. Because the measurements occur in successive steps, the uncertainty in one step necessarily contributes to that in the subsequent step. As we perform statistical analysis on these types of experiments, we must learn to account for the propagation of uncertainty from one step to the next. The propagation of uncertainty depends on the type of arithmetic operation performed on...
01:10Propagation of Uncertainty from Systematic Error
The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this particular...
04:08The Uncertainty Principle
Werner Heisenberg considered the limits of how accurately one can measure properties of an electron or other microscopic particles. He determined that there is a fundamental limit to how accurately one can measure both a particle’s position and its momentum simultaneously. The more accurate the measurement of the momentum of a particle is known, the less accurate the position at that time is known and vice versa. This is what is now called the Heisenberg uncertainty principle. He mathematically...
01:15Variance
The deviations show how spread out the data are about the mean. A positive deviation occurs when the data value exceeds the mean, whereas a negative deviation occurs when the data value is less than the mean. If the deviations are added, the sum is always zero. So one cannot simply add the deviations to get the data spread. By squaring the deviations, the numbers are made positive; thus, their sum will also be positive.The standard deviation measures the spread in the same units as the data.